Overview
- 4 public-safe observations are available for this inspection.
- 4 structured CFR citations are represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
26 Nov 2013
21 CFR 111.75(a)(1)(i)
Component - verify identity, dietary ingredient
Cited by Meredith P Soehl
26 Nov 2013
21 CFR 111.83(b)(1)
Reserve sample container-closure contamination,deterioration
Cited by Meredith P Soehl
26 Nov 2013
21 CFR 111.303
Written procedures - tests, examinations; specifications met
Cited by Meredith P Soehl
Inspected site
KPKabco Pharmaceuticals, Inc.Amityville, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 111.210(g) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.303 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.75(a)(1)(i) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.83(b)(1) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 4 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere